The Zika virus attacks tissues in the nervous system, male and female reproductive and urinary tracts, muscles, joints and lymph nodes, and persists for at least 35 days, according to a study conducted in a nonhuman primate model by a multidisciplinary team of researchers at OHSU in Portland, Oregon.
A drug that works by targeting and blocking some of the body’s chemical messengers, which can become overactive in allergic reactions, shows promise in reducing symptoms caused by a severe form of eczema.
A study published in the March issue of the journal Health Affairs suggests Oregon’s experimental approach to Medicaid delivery is a viable way to control overall coverage costs.
The OHSU Knight Cancer Institute and Legacy Health have signed business agreements with The Vancouver Clinic, or TVC, to expand their network of integrated adult cancer care clinics to southwest Washington. The agreement is the latest addition to the OHSU Knight-Legacy Health Cancer Collaborative, established in 2013.
Fatemeh Reshad, a 4-month-old Iranian infant, who traveled to OHSU Doernbecher Children’s Hospital for life-saving heart surgery, is “doing well” her doctors confirmed at a press conference Monday, Feb. 27.
A new study reveals that administering epinephrine via a prefilled epinephrine syringe designed for adults, can result in inaccurate dosing for pediatric patients.
A powerful class of antibiotics provides life-saving relief for people with cystic fibrosis; however, a new study for the first time reveals the levels at which high cumulative dosages over time significantly increases the risk of permanent hearing loss in these patients.
Physicians in the Pacific Northwest Evidence-based Practice Center at OHSU in Portland, Oregon, played a critical role in updating recommendations for the Women’s Preventive Services Guidelines, which address a wide variety of unique health issues women face.